Chemotherapy and patient co-morbidity in ventral site hernia development

Journal of Gynecologic Oncology

Volumn 20, Issue 4, 2009, Pages 246-250

  Rettenmaier, Mark A ^a   Abaid, Lisa N ^a   Brown III, John V ^a   Micha, John P ^a   Goldstein, Bram H ^a  

^a HOAG MEMORIAL HOSPITAL PRESBYTERIAN   (United States)

Author keywords

Gynecologic cancer surgery; Herniorrhaphy; Treatment; Ventral site hernia

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; DOXORUBICIN; PACLITAXEL;

ABDOMINAL HYSTERECTOMY; ABDOMINAL WALL HERNIA; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COMORBIDITY; DIABETES MELLITUS; FEMALE; HERNIORRHAPHY; HUMAN; HYPERTENSION; INCISIONAL HERNIA; LAPAROTOMY; LENGTH OF STAY; OVARY CANCER; PELVIS LYMPHADENECTOMY; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; RISK FACTOR; SALPINGOOOPHORECTOMY; UTERINE TUBE CARCINOMA; UTERUS CANCER; WOUND HEALING IMPAIRMENT;

EID: 77958000489     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2009.20.4.246     Document Type: Article

References (27)

1. Singh R, Omiccioli A, Hegge S, McKinley C. Does the extraction-site location in laparoscopic colorectal surgery have an impact on incisional hernia rates? Surg Endosc 2008;22:2596-600.
2. Hadad I, Small W, Dumanian GA. Repair of massive ventral hernias with the separation of parts technique: reversal of the 'lost domain'. Am Surg 2009;75:301-6.
3. Cheng H, Rupprecht F, Jackson D, Berg T, Seelig MH. Decision analysis model of incisional hernia after open abdominal surgery. Hernia 2007;11:129-37.
4. Millikan K W. Incisional hernia repair. Surg Clin North Am 2003;83:1223-34.
5. El-Khadrawy OH, Moussa G, Mansour O, Hashish MS. Prophylactic prosthetic reinforcement of midline abdominal incisions in high-risk patients. Hernia 2009;13:267-74.
6. Larusson HJ, Zingg U, Hahnloser D, Delport K, Seifert B, Oertli D. Predictive factors for morbidity and mortality in patients undergoing laparoscopic paraesophageal hernia repair: age, ASA score and operation type influence morbidity. World J Surg 2009;33:980-5.
7. Wassenaar EB, Schoenmaeckers EJ, Raymakers J T, Rakic S. Recurrences after laparoscopic repair of ventral and incisional hernia: lessons learned from 505 repairs. Surg Endosc 2009;23:825-32.
8. Gangopadhyay N, Perrone JM, Soper NJ, Matthews BD, Eagon JC, Klingensmith ME, et al. Outcomes of laparoscopic paraesophageal hernia repair in elderly and high-risk patients. Surgery 2006;140:491-8.
9. Schneider A, Kohler C, Erdemoglu E. Current developments for pelvic exenteration in gynecologic oncology. Curr Opin Obstet Gynecol 2009;21:4-9.
10. O'Hanlan KA, Dibble SL, Fisher D T. Total laparoscopic hysterectomy for uterine pathology: impact of body mass index on outcomes. Gynecol Oncol 2006;103:938-41.
11. Munro MG. Laparoscopic access: complications, technologies, and techniques. Curr Opin Obstet Gynecol 2002;14:365-74.
12. Mahdavi A, Kumtepe Y, Nezhat F. Laparoscopic management of benign serous neoplasia arising from persistent ovarian remnant. J Minim Invasive Gynecol 2007;14:654-6.
13. Hoer J, Lawong G, Klinge U, Schumpelick V. Factors influencing the development of incisional hernia: a retrospective study of 2, 983 laparotomy patients over a period of 10 years. Chirurg 2002;73:474-80.
14. Vermulst N, Vermeulen J, Hazebroek EJ, Coene P P, van der Harst E. Primary closure of the skin after stoma closure: management of wound infections is easy without (long-term) complications. Dig Surg 2006;23:255-8.
15. Hoogwerf BJ. Postoperative management of the diabetic patient. Med Clin North Am 2001;85:1213-28.
16. Shermak MA. Hernia repair and abdominoplasty in gastric bypass patients. Plast Reconstr Surg 2006;117:1145-50.
17. Geller MA, Argenta PA, Thomas SG, Dusenbery KE, Judson PL, Boente M P. Feasibility and morbidity of using saline filled tissue expanders to reduce radiation-induced bowel injury in patients with gynecologic malignancies. Eur J Obstet Gynecol Reprod Biol 2009;143:93-7.
18. Langer C, Schaper A, Liersch T, Kulle B, Flosman M, Fuzesi L, et al. Prognosis factors in incisional hernia surgery: 25 years of experience. Hernia 2005;9:16-21.
19. Zatkone Puskas G. The significance of extravasation in oncological care. Magy Onkol 2008;52:75-80.
20. Phillips TL, Fu KK. Acute and late effects of multimodal therapy on normal tissues. Cancer 1977;40(1 Suppl): 489-94.
21. Tsopanoglou NE, Maragoudakis ME. Inhibition of angiogenesis by small-molecule antagonists of protease-activated receptor-1. Semin Thromb Hemost 2007;33:680-7.
22. Micha J P, Goldstein BH, Rettenmaier MA, Genesen M, Graham C, Bader K, et al. A phase II study of outpatient first-line paclitaxel, carboplatin and bevacizumab for advanced stage epithelial ovarian, peritoneal, and fallopian tube cancer. Intl J Gynecol Cancer 2007;17:771-6.
23. Simpkins F, Belinson JL, Rose PG. Avoiding bevacizumab related gastrointestinal toxicity for recurrent ovarian cancer by careful patient screening. Gynecol Oncol 2007;107:118-23.
24. Rai S, Chandra SS, Smile SR. A study of the risk of strangulation and obstruction in groin hernias. Aust N Z J Surg 1998;68:650-4.
25. van 't Riet M, Steyerberg E W, Nellensteyn J, Bonjer HJ, Jeekel J. Meta-analysis of techniques for closure of midline abdominal incisions. Br J Surg 2002;89:1350-6.
26. Harvey P W, Petkov JN, Misan G, Fuller J, Battersby M W, Cayetano TN, et al. Self-management support and training for patients with chronic and complex conditions improves healthrelated behaviour and health outcomes. Aust Health Rev 2008;32:330-8.
27. de Jong D, Eijkemans MJ, Lie Fong S, Gerestein CG, Kooi GS, Baalbergen A, et al. Preoperative predictors for residual tumor after surgery in patients with ovarian carcinoma. Oncology 2007;72:293-301.